Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation.

about

New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury "Let them eat strawberries": Dietary restrictions for children with cancer.

P2860

Q33774917-22EE5362-2C7D-469E-BEFA-9EC4AB5D17ED Q50097093-3C17114C-7756-4052-B933-C17F38239FED

P2860

Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation.

Item

http://www.wikidata.org/entity/Q40440505

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Caphosol for prevention of ora ...... opoietic cell transplantation.

@en

type

Item

label

Caphosol for prevention of ora ...... opoietic cell transplantation.

@en

prefLabel

Caphosol for prevention of ora ...... opoietic cell transplantation.

@en

P1476

Caphosol for prevention of ora ...... opoietic cell transplantation.

@en

P2093

Amanda August

http://www.w3.org/2001/XMLSchema#string

Christina Baggott

http://www.w3.org/2001/XMLSchema#string

Ellen Olson

http://www.w3.org/2001/XMLSchema#string

Ha Dang

http://www.w3.org/2001/XMLSchema#string

Lillian Sung

http://www.w3.org/2001/XMLSchema#string

Lu Chen

http://www.w3.org/2001/XMLSchema#string

Mark Krailo

http://www.w3.org/2001/XMLSchema#string

Michael Nieder

http://www.w3.org/2001/XMLSchema#string

Nathaniel Treister

http://www.w3.org/2001/XMLSchema#string

P2860

Defining the intensity of conditioning regimens: working definitions

Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate

Palifermin for oral mucositis after intensive therapy for hematologic cancers

Efficacy of a supersaturated calcium phosphate oral rinse for the prevention and treatment of oral mucositis in patients receiving high-dose cancer therapy: a review of current data.

Patient reports of complications of bone marrow transplantation.

Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation.

A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation.

The pathobiology of mucositis.

Phase I study of the tolerability and pharmacokinetics of palifermin in children undergoing allogeneic hematopoietic stem cell transplantation.

Measurement of oral mucositis in children: a review of the literature.

P2888

bjc.2016.380

P304

21-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2016.380

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27875526

http://www.w3.org/2001/XMLSchema#string

P932

5220147

http://www.w3.org/2001/XMLSchema#string

Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation.

about

P2860

P2860

Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932